Mild Cognitive Impairment — Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment
Citation(s)
A Randomized Double-Blinded Placebo-Controlled Exploratory Study of Intravenous Immunoglobulin (NewGam 10%) in Amnestic Mild Cognitive Impairment